Adjunctive Hormone Therapy for Treatment Resistant Depression in Perimenopausal Women

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1049041

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Women entering the menopause have increased rates of treatment resistant depression with poor response to standard antidepressant treatment. We propose to conduct a clinical trial of a novel adjunctive hormone, tibolone, to improve the outcomes for middle – aged women with severe depression.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $620,946.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antidepressant therapy | depression | hormones | menopause | psychiatry | women's health

Related Links